CYTK as of Nov 2 · 07:58 ET

CYTKNasdaqPharmaceutical Preparations

Cytokinetics Inc · Brief

Next report

2 days

Nov 4 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±7.7%implied · report alone

58.1567.83

straddle ±9.7%

spot 62.99exp Nov 20ATM strike 62.5ATM straddle 7.23IV 60%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±10.2%
avg realized: ±4.1%

Aug 8 '24±14.7%▲+3.31%×0.23

Feb 27 '25±13.7%▼−3.06%×0.22

May 6 '25±10.0%▼−2.74%×0.27

Aug 7 '25±6.1%▼−3.23%×0.53

Q3 FY25±8.9%▲+1.88%×0.21

Feb 24 '26±10.0%▼−10.29%×1.03

Q1 FY26±10.5%▼−2.92%×0.28

Q2 FY26±7.7%▼−5.67%×0.73

quarterimplied−15%0+15%realized×

Q2 FY26±7.7%▼−5.67%×0.73

Q1 FY26±10.5%▼−2.92%×0.28

Feb '26±10.0%▼−10.29%×1.03

Q3 FY25±8.9%▲+1.88%×0.21

Aug '25±6.1%▼−3.23%×0.53

May '25±10.0%▼−2.74%×0.27

2 older reports

Feb '25±13.7%▼−3.06%×0.22

Aug '24±14.7%▲+3.31%×0.23

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

+6.24%ten largest reporting managers increased shares over the latest quarter13F · Jun 30 '26

487managers reporting a position in the latest quarterly filings indicate broad holdings13F · Jun 30 '26

Bear2

4 of 25largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

7 of 8recent reports where the move came in under the options implied rangeEarnings history

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CYTK report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±10.6% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.